Circulogene Theranostics

Business Area(s): 
Description: 

Circulogene's “liquid biopsy” is based on the discovery that as tumors grow, they also die, releasing their DNA into the bloodstream. Circulogene's liquid biopsy tumor DNA sequencing is the only test available that combines minimal volumes of blood with next-generation sequencing (NGS) to monitor tumor-mutant DNA within well-characterized, well-documented, cancer-associated genes.

Location(s): 
Birmingham AL
United States